A
ALGS
Aligos Therapeutics, Inc.
7.97
+0.23+2.97%After Hours: 7.59 -0.38 -4.77%16:10 04/02 EDT
OPEN/PREV CLOSE8.25/7.90
TODAY RANGE7.78-8.58
VOL50.79K
MARKET CAP49.44M
52 WEEK RANGE3.760-13.69
AVG VOL (3M)53.43K
% TURNOVER0.82%
TURNOVER--
P/E (TTM)-3.2646
% RANGE9.65%
EPS(TTM)-2.4475
P/E(FORWARD)-1.2887
P/B0.9219
BVPS8.67
DIVIDEND--
P/S22.58
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP38.61M
SHARES OUTSTANDING6.19M
NEXT EARNINGS05/04-05/08
FREE FLOAT4.83M
LOT SIZE1
EX-DATE08/19/2024
News
Press Releases
Financial Reports
Profile
Dow Jones·03/26 14:25
Aligos Therapeutics Price Target Announced at $48.00/Share by WestPark Capital
TipRanks·03/26 13:00
Aligos Therapeutics initiated with a Buy at WestPark Capital
Dow Jones·03/19 19:50
Aligos Therapeutics Price Target Cut to $48.00/Share From $60.00 by Jefferies
Benzinga·03/19 19:40
Jefferies Assumes Aligos Therapeutics at Buy, Lowers Price Target of $48
TipRanks·03/19 09:15
Aligos Therapeutics assumed with a Buy at Jefferies
Seeking Alpha·03/05 18:02
Aligos Therapeutics GAAP EPS of -$1.91 beats by $0.12
TipRanks·03/05 13:14
Aligos Therapeutics reports Q4 EPS ($1.91), consensus ($2.49)
Benzinga·03/05 13:14
Aligos Therapeutics Earnings Report: Q4 Overview
Reuters·03/05 13:10
Aligos Therapeutics Q4 net loss narrows
Same Industry
Name/Symbol
Change%
Price